Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

TONIX Pharmaceuticals Completes Pharmacokinetic Study on New Formulation of TNX-102 for Fibromyalgia
Genetic Engineering & Biotechnology News
Saturday, April 7, 2012 - 12:31pm
tags:
Tonix Pharmaceuticals, TNX-102, fibromyalgia
Growing drug demand means high times for global biotech
Nasdaq
Saturday, April 7, 2012 - 12:29pm
tags:
FDA Approves Amyvid™ (Florbetapir F 18 Injection) for Use in Patients Being Evaluated for Alzheimer's Disease and Other Causes of Cognitive Decline
Yahoo/PR NewsWire
Saturday, April 7, 2012 - 11:58am
tags:
Amyvid, Avid Radiopharmaceuticals, Eli Lilly
Novo Nordisk says diabetes drug Victoza superior to Merck rival
Reuters
Saturday, April 7, 2012 - 11:56am
tags:
Novo Nordisk, Victoza, Merck, Januvia, diabetes
Failure of Another Trial Testing Guided Antiplatelet Therapy Prompts Debate
Forbes
Saturday, April 7, 2012 - 11:55am
tags:
antiplatelet therapy, Target-PCI
Is Pfizer a Buffett Stock?
Motley Fool
Saturday, April 7, 2012 - 11:53am
tags:
Pfizer
Roche Willing to Consider Added ‘Value’ in Illumina Bid
Bloomberg
Saturday, April 7, 2012 - 11:52am
tags:
Roche, Illumina, M&A
Leading Proxy Advisory Firms Issue Reports in Strong Support of Illumina
Yahoo/BusinessWire
Saturday, April 7, 2012 - 11:51am
tags:
Roche, Illumina, M&A
1 Biotech With Room to Run (video)
Motley Fool
Saturday, April 7, 2012 - 11:50am
tags:
Affymax
Roche’s Hostile Bid Undervalues Illumina, ISS Says
Bloomberg
Saturday, April 7, 2012 - 11:48am
tags:
Roche, Illumina, M&A
GenVec Announces Research on Improved Vaccine Vectors
Yahoo/PR NewsWire
Saturday, April 7, 2012 - 11:44am
tags:
GenVec, vaccines
Biotech vets back $22M A round for neuroscience startup
Fierce Biotech
Friday, April 6, 2012 - 12:54pm
tags:
Alba Therapeutics, start-ups, Cerecor
Novartis Compound Spurs Cartilage in Arthritic Mice
Bloomberg
Friday, April 6, 2012 - 12:44pm
tags:
Novartis, arthritis, stem cells
KV Pharmaceutical execs get thousands in bonuses
Bizjournals.com
Friday, April 6, 2012 - 12:25pm
tags:
KV Pharmaceutical, executive pay
Growing drug demand means high times for global biotech
NASDAQ.com
Friday, April 6, 2012 - 12:21pm
tags:
biotech, generics
Sucampo says lubiprostone worked in late-stage trial; will file for FDA approval in mid-2012
Yahoo/AP
Friday, April 6, 2012 - 11:53am
tags:
Sucampo, Lubiprostone, opioid-induced bowel dysfunction
Watchdog says FDA should consider restricting Gilenya
Fierce Pharma
Friday, April 6, 2012 - 11:50am
tags:
FDA, Gilenya, Novartis, multiple sclerosis, MS
Teva selling generic version of Provigil; says Par will start selling its own generic Friday
Yahoo/AP
Friday, April 6, 2012 - 11:43am
tags:
Provigil, Par Pharmaceutical, Teva Pharmaceuticals, generics
I.S.S. Sides With Illumina in Proxy Fight Against Roche
NY Times, NY
Friday, April 6, 2012 - 11:16am
tags:
M&A, Illumina, Roche
Affymax Poised To Take On Amgen?
Seeking Alpha
Friday, April 6, 2012 - 11:15am
tags:
Amgen, Affymax, Regeneron, Alnylam, Omontys, chronic kidney disease

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.